Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryo Shimizu

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Tissue Engineering. Part A|November 15, 2014
Repair mechanism of osteochondral defect promoted by bioengineered chondrocyte sheetRyo Shimizu, Naosuke Kamei, Nobuo Adachi, et al.
Gut and Liver|May 17, 2017
Simeprevir-Based Triple Therapy with Reduced Doses of Pegylated Interferon α-2a Plus Ribavirin for Interferon Ineligible Patients with Genotype 1b Hepatitis C VirusHideyuki Tamai, Yoshiyuki Ida, Akira Kawashima, et al.
DEN Open|December 4, 2023
Advantage of magnifying narrow-band imaging for the diagnosis of colorectal neoplasia associated with sessile serrated lesionsYuri Enomoto, Mitsuaki Ishioka, Akiko Chino, et al.
Biomedical Reports|July 15, 2015
Efficacy of recombinant human soluble thrombomodulin in patients with sepsis and disseminated intravascular coagulation in the gastroenterology fieldTomoyasu Ito, Akihito Nagahara, Taro Osada, et al.
CEN Case Reports|February 24, 2022
A case of juvenile-onset fibrillary glomerulonephritis diagnosed by mass spectrometry and immunohistochemistry of DNAJB9Keita Hattori, Ryo Shimizu, Shoichiro Tanaka, et al.
Gut and Liver|August 12, 2017
The Real-World Safety and Efficacy of Daclatasvir and Asunaprevir for Elderly PatientsShinya Taki, Hideyuki Tamai, Yoshiyuki Ida, et al.
World Journal of Hepatology|October 9, 2020
Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and overHideyuki Tamai, Naoki Shingaki, Yoshiyuki Ida, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 9, 2019
Real-world safety and efficacy of sofosbuvir and ledipasvir for elderly patientsHideyuki Tamai, Naoki Shingaki, Yoshiyuki Ida, et al.
World Journal of Gastrointestinal Endoscopy|November 3, 2016
Prior minimal endoscopic sphincterotomy to prevent pancreatitis related to endoscopic balloon sphincteroplastyRyo Kanazawa, Jin Kan Sai, Tomoyasu Ito, et al.
ACS Applied Nano Materials|August 9, 2023
Lethal Interactions of SARS-CoV-2 with Graphene Oxide: Implications for COVID-19 TreatmentMasahiro Fukuda, M Saidul Islam, Ryo Shimizu, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Tissue Engineering. Part A|November 15, 2014
Repair mechanism of osteochondral defect promoted by bioengineered chondrocyte sheetRyo Shimizu, Naosuke Kamei, Nobuo Adachi, et al.
Gut and Liver|May 17, 2017
Simeprevir-Based Triple Therapy with Reduced Doses of Pegylated Interferon α-2a Plus Ribavirin for Interferon Ineligible Patients with Genotype 1b Hepatitis C VirusHideyuki Tamai, Yoshiyuki Ida, Akira Kawashima, et al.
DEN Open|December 4, 2023
Advantage of magnifying narrow-band imaging for the diagnosis of colorectal neoplasia associated with sessile serrated lesionsYuri Enomoto, Mitsuaki Ishioka, Akiko Chino, et al.
Biomedical Reports|July 15, 2015
Efficacy of recombinant human soluble thrombomodulin in patients with sepsis and disseminated intravascular coagulation in the gastroenterology fieldTomoyasu Ito, Akihito Nagahara, Taro Osada, et al.
CEN Case Reports|February 24, 2022
A case of juvenile-onset fibrillary glomerulonephritis diagnosed by mass spectrometry and immunohistochemistry of DNAJB9Keita Hattori, Ryo Shimizu, Shoichiro Tanaka, et al.
Gut and Liver|August 12, 2017
The Real-World Safety and Efficacy of Daclatasvir and Asunaprevir for Elderly PatientsShinya Taki, Hideyuki Tamai, Yoshiyuki Ida, et al.
World Journal of Hepatology|October 9, 2020
Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and overHideyuki Tamai, Naoki Shingaki, Yoshiyuki Ida, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 9, 2019
Real-world safety and efficacy of sofosbuvir and ledipasvir for elderly patientsHideyuki Tamai, Naoki Shingaki, Yoshiyuki Ida, et al.
World Journal of Gastrointestinal Endoscopy|November 3, 2016
Prior minimal endoscopic sphincterotomy to prevent pancreatitis related to endoscopic balloon sphincteroplastyRyo Kanazawa, Jin Kan Sai, Tomoyasu Ito, et al.
ACS Applied Nano Materials|August 9, 2023
Lethal Interactions of SARS-CoV-2 with Graphene Oxide: Implications for COVID-19 TreatmentMasahiro Fukuda, M Saidul Islam, Ryo Shimizu, et al.
Pageof 12